Development and validation of the HPLC–MS/MS method and its application to the pharmacokinetic study for the Mongolian drug Sendeng-4 in rat blood plasma
AbstractSendeng-4 is a Mongolian drug. The Mongolian people have been using it to treat rheumatoid arthritis. At present, an increasing number of Han people are paying attention to the anti-rheumatoid effect of Sendeng-4. However, information on the pharmacokinetics of Sendeng-4 is limited, which li...
Saved in:
| Main Authors: | Pu Bai, Yu Dong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1547415/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bioanalytical assay for the quantification of rucaparib in rat plasma using UPLC-MS/MS: development, and validation for interaction with myricetin
by: Jingjing Nie, et al.
Published: (2025-05-01) -
Development of a UPLC-MS/MS method for the determination of sulfatinib and its no interaction with myricetin in rats
by: Dongxin Chen, et al.
Published: (2024-12-01) -
Development and Validation of an HPLC-MS/MS Method for the Simultaneous Quantification of Vitexin and Isovitexin in Rabbit Plasma: Pharmacokinetic Insights on a Microcapsule Formulation
by: Duc Tuan Nguyen, et al.
Published: (2025-04-01) -
Development and validation of LC-MS/MS method for tomivosertib quantification in plasma: insights into pharmacokinetics and metabolic stability
by: Mamata Panthi, et al.
Published: (2025-07-01) -
Development and Validation of an LC–MS/MS Method for Quantifying Gabapentin in Plasma: Application to a Pharmacokinetic Study in Cats
by: Feifei Zhao, et al.
Published: (2025-03-01)